QA: Alpine Immune Sciences INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001626199_2023_Alpine_Immune_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001626199, Alpine Immune Sciences INC

  xvar xval
0 AssetsCurrent 240,993,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,584,000
3 remainder_Assets 44,109,000
4 LiabilitiesCurrent 57,996,000
5 LiabilitiesNoncurrent 49,270,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 19,446,473
9 ResearchAndDevelopmentExpense 69,939,693
10 remainder_Expenses 1,896,212
11 remainder_Revenues 50,183,354
12 remainder_NetIncome 2,088,608
13 remainder_ComprehensiveNetIncome -3,451,604
  yvar yval
0 Assets 286,686,000
1 Liabilities 107,266,000
2 Expenses 91,282,378
3 Revenues 50,183,354
4 StockholdersEquity 179,420,000
5 NetIncome -39,010,416
6 ComprehensiveNetIncome -40,736,218
7 BaseVar 270,478,972
8 EconomicCapitalRatiobeforeLimitedLiability 1.78
9 EconomicCapitalRatio 2.87

Edgar->Model Mapping

Feature Distribution

Change over Time